OPRL1 anticorps (C-Term)

N° du produit ABIN6258295

Détail du produit anti-OPRL1 anticorps

Antigène: OPRL1 (Opiate Receptor-Like 1 (OPRL1))

Épitope: C-Term

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp OPRL1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Specificité: OPRL1 Antibody detects endogenous levels of total OPRL1.

Homologie: Pig,Horse,Sheep,Dog

Purification: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogène: A synthesized peptide derived from human OPRL1, corresponding to a region within C-terminal amino acids.

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:2000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Date de péremption: 12 months

Détails sur OPRL1

Antigène: OPRL1 (Opiate Receptor-Like 1 (OPRL1))

Autre désignation: OPRL1 (OPRL1 Produits)

Synonymes: anticorps KOR-3, anticorps NOCIR, anticorps OOR, anticorps ORL1, anticorps KOR3, anticorps LC132, anticorps MOR-C, anticorps OFQR, anticorps Oprl, anticorps XOR1, anticorps OPRL, anticorps ORGC, anticorps morc, anticorps opioid related nociceptin receptor 1, anticorps opiate receptor-like 1 L homeolog, anticorps opiate receptor-like 1, anticorps opioid receptor-like 1, anticorps OPRL1, anticorps oprl1.L, anticorps LOC100335303, anticorps Oprl1

Sujet:

Description: G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.

Gene: OPRL1

Poids moléculaire: 41 kDa,

ID gène: 4987

UniProt: P41146